15 results on '"Huien Wang"'
Search Results
2. Benign esophageal schwannoma: A case report
- Author
-
Huien Wang, Yifan Li, Meiqi Wu, and Hongshang Cui
- Subjects
Surgery ,RD1-811 - Published
- 2023
- Full Text
- View/download PDF
3. Meta-analysis of association between CT-based features and tumor spread through air spaces in lung adenocarcinoma
- Author
-
Qifan Yin, Huien Wang, Hongshang Cui, Wenhao Wang, Guang Yang, Peng Qie, Xuejiao Xun, Shaohui Han, and Huining Liu
- Subjects
Spread through air spaces ,CT-based features ,Lung adenocarcinoma ,Association ,Meta-analysis ,Surgery ,RD1-811 ,Anesthesiology ,RD78.3-87.3 - Abstract
Abstract Objective Spread through air space (STAS) is a novel invasive pattern of lung adenocarcinoma and is also a risk factor for recurrence and worse prognosis of lung adenocarcinoma after sublobar resection. The aims of this study are to evaluate the association between computed tomography (CT)-based features and STAS for preoperative prediction of STAS in lung adenocarcinoma, eventually, which could help us choose appropriate surgical type. Methods Systematic research was conducted to search for studies published before September 1, 2019. The association between CT-based features of radiological tumor size>2 cm、pure solid nodule、 part-solid nodule or Percentage of solid component (PSC)>50% and STAS was evaluated. According to rigorous inclusion and exclusion criteria. Eight studies including 2385 patients published between 2015 and 2018 were finally enrolled in our meta-analysis. Results Our results clearly depicted that there is no significant relationship between radiological tumor size>2 cm and STAS with the combined OR of 1.47(95% CI:0.86–2.51). Meta-analysis of 3 studies showed that pure solid nodule in CT image were more likely to spread through air spaces with pooled OR of 3.10(95%CI2.17–4.43). Meta-analysis of 5 studies revealed the part-solid nodule in CT image may be more likely to appear STAS in adenocarcinoma (ADC) (combined OR:3.10,95%CI:2.17–4.43). PSC>50% in CT image was a significant independent predictor in the diagnosis of STAS in ADC from our meta-analysis with combined OR of 2.95(95%CI:1.88–4.63). Conclusion In conclusion, The CT-based features of pure solid nodule、part-solid nodule、PSC>50% are promising imaging biomarkers for predicting STAS in ADC and may substantially influence the choice of surgical type. In future, more studies with well-designed and large-scale are needed to confirm the conclusion.
- Published
- 2020
- Full Text
- View/download PDF
4. The adverse maternal and perinatal outcomes of adolescent pregnancy: a cross sectional study in Hebei, China
- Author
-
Ting Zhang, Huien Wang, Xinling Wang, Yue Yang, Yingkui Zhang, Zengjun Tang, and Li Wang
- Subjects
Adolescent ,Pregnancy ,Maternal outcomes ,Perinatal outcomes ,Gynecology and obstetrics ,RG1-991 - Abstract
Abstract Background The adverse pregnancy outcomes caused by teenage pregnancy are major public health problems with significant social impact. While China is the most populous country in the world, and 8.5% of the women aged 10–50 years are adolescent women, we aimed to analyze the adverse maternal and perinatal outcomes of the adolescent pregnancy in Hebei Province, China. Methods There were 238,598 singleton pregnant women aged 10–34 years from January 1, 2013 to December 31, 2017 in the database of Hebei Province Maternal Near Miss Surveillance System (HBMNMSS). The 238,598 pregnant women were divided into two groups: adolescent group (aged 10–19 years) and adult group (aged 20–34 years). The adolescent group was divided into two subgroups (aged 10–17 years, aged 18–19 years), the adult group was divided into two subgroups (aged 20–24 years, aged 25–34 years). We compared the risk of adverse pregnancy outcomes using univariate and multivariate logistic regression. We also made a stratified analysis of nulliparous and multiparous adolescent pregnancy. Results Compared with women aged 20–34 years, women aged 10–19 years had lower risk of cesarean delivery [adjusted risk ratio (aRR): 0.75, 95% confidence interval (CI): 0.70–0.80], gestational diabetes mellitus (GDM) (aRR: 0.55, 95%CI: 0.41–0.73). Women aged 10–19 years had higher risk of preterm delivery (aRR: 1.76, 95%CI: 1.54–2.01), small for gestational age (SGA) (aRR: 1.19, 95%CI: 1.08–1.30), stillbirth (aRR: 2.58, 95%CI: 1.83–3.62), neonatal death (aRR: 2.63, 95%CI: 1.60–4.32). The adolescent women aged 10–17 years had significantly higher risk of stillbirth (aRR: 5.69, 95%CI: 3.36–9.65) and neonatal death (aRR: 7.57, 95%CI: 3.74–15.33) compared with the women aged 25–34 years. Younger adults (20–24 years) also had higher risks of preterm delivery (aRR: 1.26, 95%CI: 1.20–1.32), stillbirth (aRR: 1.45, 95%CI: 1.23–1.72), and neonatal death (aRR: 1.51, 95%CI: 1.21–1.90) compared with women aged 25–34 years. The structural equation model showed that preterm delivery and cesarean delivery had an indirect effect on neonatal death in adolescent pregnancy. Conclusions The adolescent pregnancy was related to adverse perinatal (fetal and neonatal) outcomes, such as preterm delivery, stillbirth and neonatal death, especially in younger adolescent pregnancies.
- Published
- 2020
- Full Text
- View/download PDF
5. Role of circulating tumor cells in diagnosis of lung cancer: a systematic review and meta-analysis
- Author
-
Qingtao Zhao, Zheng Yuan, Huien Wang, Hua Zhang, Guochen Duan, and Xiaopeng Zhang
- Subjects
Medicine (General) ,R5-920 - Abstract
Objective We systematically reviewed the literature relating to the diagnostic accuracy of circulating tumor cells (CTCs) for the clinical determination of lung cancer. Methods This meta-analysis aimed to evaluate the diagnostic accuracy of CTCs for the clinical determination of lung cancer. The PubMed, Embase, Cochrane Library, and Web of Science databases were searched for relevant studies up to 31 May 2020. The numbers of patients with true positive, false positive, false negative, and true negative results were extracted from each individual study. Pooled sensitivity, specificity, and area under the curve values were calculated with 95% confidence intervals (CI). Results Twenty-one studies with 3997 subjects met the inclusion criteria. The overall diagnostic accuracy was assessed. The pooled sensitivity and specificity were 0.72 (95%CI: 0.65–0.79) and 0.96 (95%CI: 0.91–0.98), respectively, and the pooled positive and negative likelihood ratios were 16.86 (95%CI: 7.65–37.12) and 0.29 (95%CI: 0.23–0.37), respectively. The combined diagnostic odds ratio was 58.12 (95%CI: 24.82–136.09). Conclusion This meta-analysis indicated that CTCs had good diagnostic value for detecting lung cancer.
- Published
- 2021
- Full Text
- View/download PDF
6. Comparative analysis of the clinical effects of different thoracoscopic resection in the treatment of Stage I Non-Small Cell Lung Cancer.
- Author
-
Hao Jiang, Tong Wu, Peng Qie, Huien Wang, and Baoxin Zhang
- Subjects
NON-small-cell lung carcinoma ,SURGICAL blood loss ,SURGICAL complications ,VITAL capacity (Respiration) ,POSTOPERATIVE pain ,LOBECTOMY (Lung surgery) - Abstract
Objective: To compare and analyze the clinical effects of thoracoscopic lobectomy and segmentectomy in stage I nonsmall cell lung cancer (NSCLC). Method: This was a retrospective study. Eighty patients with stage I NSCLC treated in Cangzhou People’s Hospital from December 2019 to January 2022 were randomly divided into the segmentectomy group and lobectomy group, with 40 cases in each group. Further comparative analysis was carried out focusing on perioperative indexes, maximum ventilation volume (MVV), forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), VAS score of postoperative pain and complications. Result: There was no significant difference in the number of dissected lymph nodes and extubation time between the two groups (p>0.05). The operation time was longer, while intraoperative blood loss was less and the stay of stay in hospital was shorter in the segmentectomy group significantly than those in the lobectomy group (p<0.05). Furthermore, no significant difference was observed in MVV%, FVC% and FEV1% between the two groups before operation (p>0.05). Meanwhile, the segmentectomy group had evidently lower VAS scores at 1 d, 3 d and 5 d postoperatively than those in the lobectomy group (p<0.05). Besides, there was a much lower total incidence of complications in the segmentectomy group than that in the lobectomy group (p<0.05). Conclusion: Compared with lobectomy, thoracoscopic segmentectomy is more effective in the treatment of stage I NSCLC, with less bleeding and mild pain, which can alleviate pulmonary function injury and reduce postoperative complications that is conducive to the improved prognosis of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. The efficacy and safety of radiofrequency ablation in the treatment of inoperable patients with pulmonary malignant nodules
- Author
-
Peng Qie, Xuejiao Xun, Xiaodong Nie, Qifan Yin, Hongshang Cui, Lijun Liu, and Huien Wang
- Abstract
Objective: Radiofrequency ablation(RFA) has been recently applied as an alternative treatment in the patients with pulmonary malignancies. The aim of our study was to assess the incidence of complications and survival rate of RFA for malignant lung nodules, and evaluate the efficacy and safety of RFA in the treatment of inoperable patients with pulmonary malignant nodules. Methods: The clinical data of 50 patients (34 men and 16 women) aged 74.2(range 65-84) years with primary(n=42) and metastatic(n=8) lung malignant nodules treated with RFA from June 2015 and July 2017 in Hebei General Hospital were considered for this study, and the characteristics and clinical data of these patients were analyzed. Complications, progression-free survival, and overall survival at 1, 2 and 5 years of these patients were evaluated. Results: Following the procedure. There were no major complications and deaths during the operation. 26(52%) patients presented mild-to-moderate chest pain that was easily controlled by analgesic drugs. 8(16%) patients with pneumothorax, 4(8%) haemoptysis, 6(12%) pneumonia, 7(14%) pleural effusion, and 1(2%) postoperative bronchopleural fistula. Needle-track implantation was observed in 2(4%) patients. Median progression-free survival(PFS) was 24.6 months(range, 6.8-60 months). The PFS at 1, 2, 5 years was 76%, 52%, and 20% respectively. Median overall survival(OS) was 35.5 months (range 10.2-60 months). The OS at 1, 2, and 5 years was 80%, 58%, and 32%, respectively. Conclusion: RFA is a safe and effective alternative treatment for the inoperable patients with primary or metastatic pulmonary malignant nodules. The clinical impact and long-term results of RFA need to be further confirmed in a larger series of patients, and RFA should ideally be compared with surgery.
- Published
- 2022
- Full Text
- View/download PDF
8. A Case Report of a Patient with Right Aortic Arch Complicated the Esophageal Perforation
- Author
-
Peng Qie, Qifan Yin, Xuejiao Xun, Shaohui Han, Xiaoning Li, and Huien Wang
- Abstract
Introduction: A 73-year-old female patient with right-sided aortic arch and permanent pacemaker installed was brought to Hebei General Hospital because of esophageal perforation at the first esophageal stenosis. Concerns of the patient: She had severe chest pain as well as fever. Despite being treated with fasting, gastrointestinal decompression, anti-inflammation and other methods, but she did not find relief from her pain.Diagnosis: The radiography revealed esophageal perforation at the initial esophageal stenosis. A right-sided aortic arch, anterosuperior mediastinal gas density shadow, and atelectasis of both inferior lobes of the lungs were discovered on a chest CT scan.Intervention: The abscess in the mediastinum was cleaned with surgery, and mediastinal drainage was performed using a thoracoscope. Following the surgery, the patient had underwent ongoing gastric decompression, duodenal feeding, and anti-inflammation therapy.Outcomes: The patient was successfully fed and discharged from the hospital on the 14 postoperative day.Conclusion: The therapeutic management of this condition was hampered by a number of reasons. The most important thing is to identify the major inconsistency, select a good surgical approach, and develop an adequate perioperative care strategy.
- Published
- 2022
- Full Text
- View/download PDF
9. The value of ctDNA in predicting postoperative recurrence of non-small cell lung cancer: a meta-analysis and systematic review
- Author
-
Yifan Li, Qifan Yin, Peng Qie, Shaohui Han, Xiaoning Li, Shaohui Zhou, Guibin Zhang, and Huien Wang
- Abstract
Objective: Lung cancer is the most common malignant tumor worldwide, and non-small cell lung cancer(NSCLC) accounts for approximately 85% of all lung carcinoma cases. Despite surgical operation is still the primary method for treating early NSCLC, there are still a considerable postoperative recurrence patients even after complete resection. Currently, circulating tumor DNA(ctDNA) is being recognised as a molecular biomarker of minimal residual disease(MRD) in predicting postoperative recurrence of NSCLC in clinical trials and has not been confirmed. The goal of our study is to evaluate the value of ctDNA in predicting postoperative recurrence in NSCLC patients.Method: A comprehensive systematic literature research was performed for studies exploring the value of ctDNA in predicting postoperative recurrence in NSCLC patients up to February 2022. The eligible studies were collected, and the dependent variable analysis was performed to compare the relative risk (RR) of recurrence in the postoperative ctDNA positive and negative groups. The relative ratio (RR) and 95 % confidence interval (CI) were determined as comparative measures of postoperative recurrence-free survival (RFS). Ten researches comprising 799 patients, published between 2017 and February 2022, were finally enrolled into our meta-analysis.Result: A total of 10 studies including 799 patients were summarized for meta-analysis of ctDNA in predicting recurrence in NSCLC. The combined RR was 3.75 ( 95 % CI : 1.98-4.72, P < 0.05 ), which indicated that patients with postoperative ctDNA positive had a higher postoperative recurrence rate in NSCLC than postoperative ctDNA negative. In addition, Meta-analysis of 4 studies with available data showed that preoperative peripheral blood ctDNA positive showed poor prognosis of RFS with combined HR = 3.40(95%CI: 2.72-4.69, P < 0.05).Conclusion: For NSCLC patients, ctDNA is a promising biomarker for predicting postoperative recurrence, which can be used as a supplement to the current monitoring of radiation and blood biomarkers to better guide the treatment selection and prognosis of patients after surgery.
- Published
- 2022
- Full Text
- View/download PDF
10. Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)
- Author
-
Jianxing He, Hengrui Liang, Wei Wang, Andrey Akopov, Alberto Aiolfi, Keng-Leong Ang, Luca Bertolaccini, Kaican Cai, Qingdong Cao, Baojun Chen, Chang Chen, Chun Chen, Donglai Chen, Fengxia Chen, Jun Chen, Lei Chen, Mingwu Chen, Yongbing Chen, Zhuxing Chen, Chao Cheng, Dong Cui, Fei Cui, Tianyang Dai, Qinglong Dong, Paolo A. Ferrari, Raja M. Flores, Junke Fu, Soichiro Funaki, Marios E. Froudarakis, Xiangfeng Gan, Mingfei Geng, Jialong Guo, Qiang Guo, Yongtao Han, Jintao He, Kaiming He, Kyoji Hirai, Jian Hu, Shuqiao Hu, Jian Huang, Jun Huang, Wenfa Jiang, Kyung Soo Kim, Gabor Kiss, Fanyi Kong, Lan Lan, Xuefeng Leng, Bin Li, Gaofeng Li, Hecheng Li, Hefei Li, Heng Li, Jiwei Li, Xiaoqiang Li, Shuben Li, Yinfen Li, Zhuoyi Li, Yi Liang, Lixia Liang, Wenhua Liang, Yongde Liao, Wanli Lin, Xu Lin, Hongxu Liu, Hui Liu, Jixian Liu, Jun Liu, Xiang Liu, Zihao Liu, Xingzhao Lu, Qingquan Luo, Naiquan Mao, Qi Pan, Dazhi Pang, Jun Peng, Eugenio Pompeo, Rulin Qian, Kun Qiao, Bassam Redwan, Zi Sang, Wenlong Shao, Jianfei Shen, Weiyu Shen, Sook-Whan Sung, Wenfang Tang, Tianhu Wang, Guangsuo Wang, Haitao Wang, Huien Wang, Jiyong Wang, Wen Wang, Yongyong Wang, Zhenyuan Wang, Li Wei, Wei Wei, Hao Wu, Jie Wu, Zhaohua Xia, Chenyang Xu, Enwu Xu, Hai Xu, Ning Xu, Quan Xu, Rongyu Xu, Shun Xu, Chaokun Yang, Hanyu Yang, Shengli Yang, Jun Yi, Guangjian Zhang, Hao Zhang, Jia Zhang, Man Zhang, Xiao Zhang, Yajie Zhang, Zhe Zhang, Zhifeng Zhang, Honglin Zhao, Jian Zhao, Xiaodong Zhao, Jianping Zhou, Yanran Zhou, Chengchu Zhu, Shaojin Zhu, Xinhai Zhu, Jian Cui, Yubo Yan, and Ke-Neng Chen
- Subjects
Protocol (science) ,medicine.medical_specialty ,Consensus ,business.industry ,General surgery ,MEDLINE ,Expert consensus ,medicine.disease ,Oncology ,Video assisted thoracic surgery ,Settore MED/21 ,medicine ,Lung cancer ,business - Published
- 2021
11. Meta-Analysis of Association between CT-based Features and Tumor Spread Through Air Spaces in Lung Adenocarcinoma
- Author
-
Wenhao Wang, Hongshang Cui, Guang Yang, Peng Qie, Huien Wang, Qifan Yin, Shaohui Han, Xuejiao Xun, and Huining Liu
- Subjects
Lung adenocarcinoma ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Lung Neoplasms ,lcsh:Surgery ,Adenocarcinoma of Lung ,Adenocarcinoma ,030204 cardiovascular system & hematology ,Association ,lcsh:RD78.3-87.3 ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,medicine ,Humans ,Neoplasm Invasiveness ,Risk factor ,Neoplasm Staging ,Lung ,Tumor size ,business.industry ,Air ,lcsh:RD1-811 ,General Medicine ,Prognosis ,medicine.disease ,CT-based features ,Meta-analysis ,medicine.anatomical_structure ,lcsh:Anesthesiology ,Cardiothoracic surgery ,030220 oncology & carcinogenesis ,Radiological weapon ,Inclusion and exclusion criteria ,Surgery ,Radiology ,Neoplasm Recurrence, Local ,Tomography, X-Ray Computed ,Spread through air spaces ,Cardiology and Cardiovascular Medicine ,business ,Biomarkers ,Research Article - Abstract
Objective Spread through air space (STAS) is a novel invasive pattern of lung adenocarcinoma and is also a risk factor for recurrence and worse prognosis of lung adenocarcinoma after sublobar resection. The aims of this study are to evaluate the association between computed tomography (CT)-based features and STAS for preoperative prediction of STAS in lung adenocarcinoma, eventually, which could help us choose appropriate surgical type. Methods Systematic research was conducted to search for studies published before September 1, 2019. The association between CT-based features of radiological tumor size>2 cm、pure solid nodule、 part-solid nodule or Percentage of solid component (PSC)>50% and STAS was evaluated. According to rigorous inclusion and exclusion criteria. Eight studies including 2385 patients published between 2015 and 2018 were finally enrolled in our meta-analysis. Results Our results clearly depicted that there is no significant relationship between radiological tumor size>2 cm and STAS with the combined OR of 1.47(95% CI:0.86–2.51). Meta-analysis of 3 studies showed that pure solid nodule in CT image were more likely to spread through air spaces with pooled OR of 3.10(95%CI2.17–4.43). Meta-analysis of 5 studies revealed the part-solid nodule in CT image may be more likely to appear STAS in adenocarcinoma (ADC) (combined OR:3.10,95%CI:2.17–4.43). PSC>50% in CT image was a significant independent predictor in the diagnosis of STAS in ADC from our meta-analysis with combined OR of 2.95(95%CI:1.88–4.63). Conclusion In conclusion, The CT-based features of pure solid nodule、part-solid nodule、PSC>50% are promising imaging biomarkers for predicting STAS in ADC and may substantially influence the choice of surgical type. In future, more studies with well-designed and large-scale are needed to confirm the conclusion.
- Published
- 2020
- Full Text
- View/download PDF
12. The adverse maternal and perinatal outcomes of adolescent pregnancy: a cross sectional study in Hebei, China
- Author
-
Ting Zhang, Yingkui Zhang, Huien Wang, Yue Yang, Zengjun Tang, and Li Wang
- Abstract
Background Adolescent pregnancy was a serious problem in the world, especially in developing countries. While Chinese adolescent population were about 1/4 of the total population, but have few studies focused on adolescence pregnancy in China. Thus, we aimed to clarify pregnant adverse maternal and perinatal outcomes among adolescent women by analyzing the data of childbirth in Hebei Province, a large population province in China.Methods We used the Hebei Provincial Maternal and Child Health Center Perinatal Database, including 238,598 singleton pregnancy women aged 10-34 between 2013 and 2017. They were divided into two groups: Adolescent group (10-19 years) and adult group (20-34 years), compared risk of adverse pregnancy outcomes using Poisson regression, Univariate and Multivariate Logistic Regression.Results Adolescents pregnancy women had a lower risk of cesarean delivery [adjusted risk ratio (aRR): 0.75, 95% confidence interval: 0.70-0.80] and gestational diabetes mellitus (GDM) (aRR: 0.55, 95% CI: 0.41-0.73). Adolescent pregnancy had an increased risk of preterm birth (aRR: 1.76, 95% CI: 1.54-2.01), small for gestational age (SGA) (aRR: 1.19, 95% CI: 1.08-1.30), stillbirth (aRR: 2.58, 95% CI: 1.83-3.62), neonatal death (aRR: 2.63, 95% CI: 1.60-4.32). And the risk of preeclampsia, HELLP syndrome, placenta previa, placental abruption, postpartum hemorrhage were negatively associated with adolescent pregnancy. There was a lower morbidity of anemia and a higher maternal mortality in adolescent pregnancy (P
- Published
- 2019
- Full Text
- View/download PDF
13. High serum macrophage inflammatory protein-3α is associated with the early recurrence or metastasis of non-small cell lung cancer following primary pulmonary resection
- Author
-
Aihong Meng, Xixin Yan, Huien Wang, and Xiaopeng Zhang
- Subjects
Cancer Research ,medicine.medical_specialty ,Pathology ,recurrence ,Oncogene ,macrophage inflammatory protein-3α ,business.industry ,medicine.medical_treatment ,Hazard ratio ,Cancer ,Articles ,medicine.disease ,Molecular medicine ,Gastroenterology ,Confidence interval ,Metastasis ,video-assisted thoracoscopic surgery ,Oncology ,Internal medicine ,Video-assisted thoracoscopic surgery ,medicine ,metastasis ,Lung cancer ,business ,non-small cell lung cancer - Abstract
The present study sought to characterize the role of macrophage inflammatory protein-3α (MIP-3α) in non-small cell lung cancer (NSCLC) patients with early recurrence or metastasis after primary pulmonary resection. Follow-up examinations were conducted for 203 NSCLC patients with primary pulmonary resection for two years post-operatively, and data was also collected for 20 healthy subjects. Serum MIP-3α levels were determined prior to surgery and at post-operative days (PODs) 30, 90 and 180, and the relevant clinical and operative variables were collected. Serum MIP-3α was measured using a commercially available enzyme-linked immunosorbent assay. There were no significant differences in age, gender and histological type among all groups (P>0.05). Serum MIP-3α levels on POD 180 were significantly higher in the recurrence group than in the non-recurrence group and healthy subjects (P=0.001). There was no significant difference in the serum MIP-3α level at PODs 90 and 180 in the patients with or without adjuvant chemotherapy (P>0.05). The recurrence rate in the high serum MIP-3α level group was 41.67%, much higher than the 23.53% observed in the low level group (P=0.006). The patients with high serum levels of MIP-3α had a significantly shorter overall recurrence-free time compared with those with low levels (P=0.004). Multivariate Cox’s regression analyses showed that only serum MIP-3α level was significant, with a hazard ratio of 1.061, a 95% confidence interval of 1.044–1.078 and a P-value of 0.001. The serum MIP-3α level in the patients with liver and bone metastases were remarkably higher than those with recurrence at other sites. The high post-operative serum MIP-3α levels were associated with an increased risk of post-operative early recurrence or metastasis in the lung cancer patients, specifically in those with bone or liver metastases.
- Published
- 2013
14. High serum macrophage inflammatory protein-3α is associated with the early recurrence or metastasis of non-small cell lung cancer following primary pulmonary resection.
- Author
-
XIAOPENG ZHANG, AIHONG MENG, HUIEN WANG, and XIXIN YAN
- Subjects
MACROPHAGE inflammatory proteins ,METASTASIS ,NON-small-cell lung carcinoma ,CANCER relapse ,LUNG surgery ,BLOOD proteins - Abstract
The present study sought to characterize the role of macrophage inflammatory protein-3α (MIP-3α) in non-small cell lung cancer (NSCLC) patients with early recurrence or metastasis after primary pulmonary resection. Follow-up examinations were conducted for 203 NSCLC patients with primary pulmonary resection for two years post-operatively, and data was also collected for 20 healthy subjects. Serum MIP-3α levels were determined prior to surgery and at post-operative days (PODs) 30, 90 and 180, and the relevant clinical and operative variables were collected. Serum MIP-3α was measured using a commercially available enzyme-linked immunosorbent assay. There were no significant differences in age, gender and histological type among all groups (P>0.05). Serum MIP-3α levels on POD 180 were significantly higher in the recurrence group than in the non-recurrence group and healthy subjects (P=0.001). There was no significant difference in the serum MIP-3α level at PODs 90 and 180 in the patients with or without adjuvant chemotherapy (P>0.05). The recurrence rate in the high serum MIP-3α level group was 41.67%, much higher than the 23.53% observed in the low level group (P=0.006). The patients with high serum levels of MIP-3α had a significantly shorter overall recurrence-free time compared with those with low levels (P=0.004). Multivariate Cox's regression analyses showed that only serum MIP-3α level was significant, with a hazard ratio of 1.061, a 95% confidence interval of 1.044-1.078 and a P-value of 0.001. The serum MIP-3α level in the patients with liver and bone metastases were remarkably higher than those with recurrence at other sites. The high post-operative serum MIP-3α levels were associated with an increased risk of post-operative early recurrence or metastasis in the lung cancer patients, specifically in those with bone or liver metastases. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
15. Comparative analysis of the clinical effects of different thoracoscopic resection in the treatment of Stage I Non-Small Cell Lung Cancer.
- Author
-
Jiang H, Wu T, Qie P, Wang H, and Zhang B
- Abstract
Objective: To compare and analyze the clinical effects of thoracoscopic lobectomy and segmentectomy in stage I non-small cell lung cancer (NSCLC)., Method: This was a retrospective study. Eighty patients with stage I NSCLC treated in Cangzhou People's Hospital from December 2019 to January 2022 were randomly divided into the segmentectomy group and lobectomy group, with 40 cases in each group. Further comparative analysis was carried out focusing on perioperative indexes, maximum ventilation volume (MVV), forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), VAS score of postoperative pain and complications., Result: There was no significant difference in the number of dissected lymph nodes and extubation time between the two groups (p>0.05). The operation time was longer, while intraoperative blood loss was less and the stay of stay in hospital was shorter in the segmentectomy group significantly than those in the lobectomy group (p<0.05). Furthermore, no significant difference was observed in MVV%, FVC% and FEV1% between the two groups before operation (p>0.05). Meanwhile, the segmentectomy group had evidently lower VAS scores at 1 d, 3 d and 5 d postoperatively than those in the lobectomy group (p<0.05). Besides, there was a much lower total incidence of complications in the segmentectomy group than that in the lobectomy group (p<0.05)., Conclusion: Compared with lobectomy, thoracoscopic segmentectomy is more effective in the treatment of stage I NSCLC, with less bleeding and mild pain, which can alleviate pulmonary function injury and reduce postoperative complications that is conducive to the improved prognosis of patients., Competing Interests: Conflicting of interest: None., (Copyright: © Pakistan Journal of Medical Sciences.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.